Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

Obama Policies Reshape Pharma Marketing

April 10, 2014

Health reform initiatives promote transparency, challenge reimbursement, writes Jill Wechsler.

The FORUM Format

April 7, 2014

With a new name and a veteran CEO, Deborah Dunsire, at the helm, FORUM Pharmaceuticals's flag is waving high in the increasingly solitary struggle against CNS disease.

"Market-Based" Price Controls in India?

April 2, 2014

Ram Subramanian, Nikhil Mutyal and Emma Nechamkin outline three strategic implications for pharma pricing strategies in India

Musings from the Conference Circuit: A Wake-up Call for Pharma

March 28, 2014

Bill Drummy reports on the key healthcare takeaways from this year's South by Southwest (SXSW) Interactive conference in Austin, Texas.

Italian Ruling on Roche and Novartis Resonates Across Europe

March 24, 2014

Roche and Novartis have been fined in Italy on pricing conspiracy charges, fueling a wider debate in Europe about expenditure, efficiency and off-label prescribing.

Manufacturers Struggle with FDA's "Breakthrough Drug" Development

March 21, 2014

Accelerated testing and production create challenges in documenting product quality, writes Jill Wechsler.

Population Health: The Call to Community

March 11, 2014

Population health is the foundation for much of what is truly new in US health reform. Pharm Exec talks to Dr. David Nash, Dean of the Jefferson Medical University School of Population Health.

What Do Pharma's "High Performers" Have in Common?

March 7, 2014

A study of high-performing pharma companies reveals science-based innovation strategies and patient-outcome-based commercial models are now the key drivers of growth.

The New Metrics of Market Success

March 3, 2014

Profitability now depends on metrics to help companies answer a key strategic question: "stay the course" with more investment in sales and marketing? Or "stand down" and deploy those scarce assets somewhere else?

ADVERTISEMENT

Click here